Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of the medication.

If you're one of the millions of Americans who have used or thought about using GLP-1 weight-loss drugs, it’s important to ask yourself, “What’s real, what’s safe, and what should I avoid?” In 2022, growing demand combined with limited supply created a shortage of these GLP-1 medications.